Spruce Biosciences, Inc. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$-51
Book Value Per Share
$55
Free Cash Flow Per Share
$-43
Cash Per Share
$64
Revenue Per Share
$0
OCF Per Share
$-43
Return on Equity
-109.2%
Return on Assets
-79.3%
Return on Invested Capital
-80.7%
Debt to Equity
0.00
Current Ratio
5.17
Quick Ratio
5.17
Asset Turnover
0.00
R&D / Revenue
945.2%
SBC / Revenue
108.9%
Capex / Revenue
0.0%
Working Capital
$42M
Net Current Asset Value
$42M
Invested Capital
$43M
OCF / Net Income
0.86
FCF / Net Income
0.86
Accruals Ratio (Sloan)
-10.6%
Net Debt
$-49M
Net Debt / EBITDA
1.34
Interest Coverage
-405.70
Cash Coverage
-370.30
Capex Coverage
—
Tangible Common Equity
$43M
TCE / Total Assets
80.2%
NOPAT
$-29M
Cash ROIC
-93.3%
WC / Revenue
589.7%
Capex / D&A
0.00
Reinvestment Rate
0.1%
Asset Growth vs Revenue Growth
117.3%
Book Value 5Y CAGR
-22.2%
Stock Price (FY-end)
$87
Market Cap
$67M
P/S Ratio
264.65
P/B Ratio
1.57
P/TB Ratio
1.57
Enterprise Value
$18M
EV / Sales
256.79
FCF Yield
-49.9%
Shareholder Yield
-3.9%
R&D Yield
29.2%
Capex Yield
0.0%
Shares Variation (YoY)
39.3%
Beta (5Y)
1.44
Cost of Equity
11.7%
Cost of Debt (after tax)
195.6%
52W High
$2K
52W Low
$7
Trailing Return 1Y
-96.5%
Trailing Return 5Y
-99.9%
F-Score (Piotroski)
4.00
Z-Score (Altman)
-5.14
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.